BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3126628)

  • 1. MR imaging of the gastrointestinal tract: value of Gd-DTPA.
    Laniado M; Kornmesser W; Hamm B; Clauss W; Weinmann HJ; Felix R
    AJR Am J Roentgenol; 1988 Apr; 150(4):817-21. PubMed ID: 3126628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Oral contrast media for magnetic resonance tomography of the abdomen. III. Initial patient research with gadolinium-DTPA].
    Claussen C; Kornmesser W; Laniado M; Kaminsky S; Hamm B; Felix R
    Rofo; 1988 Jun; 148(6):683-9. PubMed ID: 2837806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Oral contrast medium for magnetic resonance tomography of the abdomen. II. Phase I clinical testing of gadolinium-DTPA].
    Kornmesser W; Laniado M; Hamm B; Clauss W; Weinmann HJ; Schulz E; Wolf KJ; Felix R
    Rofo; 1987 Nov; 147(5):550-6. PubMed ID: 2825293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Oral contrast media for the magnetic resonance tomography of the abdomen. A clinical trial of the tolerance for gadolinium-DTPA].
    Kaminsky S; Laniado M; Gogoll M; Kornmesser W; Clauss W; Felix R
    Rofo; 1992 Jan; 156(1):17-23. PubMed ID: 1733470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gadolinium-DTPA as an oral contrast medium for MR tomography of the abdomen].
    Krahe T; Dölken W; Lackner K; Houselog M; Habscheid W; Clauss W
    Rofo; 1990 Aug; 153(2):167-73. PubMed ID: 2168072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gadolinium-DTPA as an oral contrast medium for magnetic resonance tomography of the pancreas].
    Neumann K; Kaminsky S; Gogoll M; Clauss W; Langer M; Felix R
    Rofo; 1991 Mar; 154(3):262-8. PubMed ID: 1849293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter double-blind placebo-controlled study of gadopentetate dimeglumine as an MR contrast agent: evaluation in patients with cerebral lesions.
    Russell EJ; Schaible TF; Dillon W; Drayer B; LiPuma J; Mancuso A; Maravilla K; Goldstein HA
    AJR Am J Roentgenol; 1989 Apr; 152(4):813-23. PubMed ID: 2646872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gadolinium-DTPA as an oral contrast medium in magnetic resonance tomography].
    Kaminsky S; Laniado M; Gogoll M; Kornmesser W; Clauss W; Felix R
    Radiol Diagn (Berl); 1989; 30(5):541-8. PubMed ID: 2587719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MR contrast enhancement of intracranial lesions with Gd-DTPA.
    Hesselink JR; Press GA
    Radiol Clin North Am; 1988 Jul; 26(4):873-87. PubMed ID: 3289078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gd-DTPA in MR of spinal lesions.
    Valk J
    AJR Am J Roentgenol; 1988 May; 150(5):1163-8. PubMed ID: 3258721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gadolinium-DTPA-enhanced MR imaging of spinal neoplasms: preliminary investigation and comparison with unenhanced spin-echo and STIR sequences.
    Stimac GK; Porter BA; Olson DO; Gerlach R; Genton M
    AJR Am J Roentgenol; 1988 Dec; 151(6):1185-92. PubMed ID: 3055895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumors of the nasopharynx and adjacent areas: MR imaging with Gd-DTPA.
    Vogl T; Dresel S; Bilaniuk LT; Grevers G; Kang K; Lissner J
    AJR Am J Roentgenol; 1990 Mar; 154(3):585-92. PubMed ID: 2154915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double contrast MR imaging with iron colloid and Gd-DTPA in cholangiocellular carcinoma.
    Suto Y; Shimatani Y; Kato T; Kamba M; Ohuchi Y; Kodama F; Kato T; Ohta Y
    Acta Radiol; 1994 Nov; 35(6):632-3. PubMed ID: 7946691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic metastases: liposomal Gd-DTPA-enhanced MR imaging.
    Unger EC; Winokur T; MacDougall P; Rosenblum J; Clair M; Gatenby R; Tilcock C
    Radiology; 1989 Apr; 171(1):81-5. PubMed ID: 2928550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gd-DTPA as a contrast agent in CT.
    Bloem JL; Wondergem J
    Radiology; 1989 May; 171(2):578-9. PubMed ID: 2704827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging.
    Hamm B; Staks T; Mühler A; Bollow M; Taupitz M; Frenzel T; Wolf KJ; Weinmann HJ; Lange L
    Radiology; 1995 Jun; 195(3):785-92. PubMed ID: 7754011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization.
    Ogan MD; Schmiedl U; Moseley ME; Grodd W; Paajanen H; Brasch RC
    Invest Radiol; 1987 Aug; 22(8):665-71. PubMed ID: 3667174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Initial experience with the use of oral gadolinium-DTPA in nuclear magnetic resonance tomography of the pelvis].
    Hötzinger H; Salbeck R; Toedt C; Beyer HK
    Digitale Bilddiagn; 1990 Jun; 10(2):42-5. PubMed ID: 2208914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging with gadolinium-DTPA for detecting cardiac transplant rejection in rats.
    Konstam MA; Aronovitz MJ; Runge VM; Kaufman DM; Brockway BA; Isner JM; Katzen NA; Dresdale AR; Diehl JT; Kaplan E
    Circulation; 1988 Nov; 78(5 Pt 2):III87-94. PubMed ID: 3052922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [3D-MR-angiography using Gd-DTPA].
    Seiderer M; Bauer WM; Villringer A; Einhäupl K
    Rofo; 1990 Mar; 152(3):327-32. PubMed ID: 2157258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.